The market for hormones in dosage except contraceptives and antibiotics in Honduras showed fluctuating growth from 2013 to 2023, with the market value reaching $26.935 million in 2023. Over the past decade, the market experienced considerable volatility, with significant growth between 2015 and 2016, stabilization from 2017 to 2019, and slight declines and recoveries in recent years. From 2019 to 2023, the market recorded an average annual growth rate (CAGR) of 3.19% indicating moderate but steady expansion, despite some declines.
Future trends to watch for include technological advancements in hormone therapies, changes in regulatory policies, and growing consumer awareness which may drive demand. Additionally, potential economic fluctuations and healthcare reforms in Honduras could further influence market dynamics.
